MétaCan
Menu
Back to cohort
Record W3127185312 · doi:10.1111/jdv.17075

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

2021· article· en· W3127185312 on OpenAlexafffund
Jennifer Beecker, Kim Papp, Jan Dutz, Ronald Vender, Robert Gniadecki, Curtis Cooper, Paolo Gisondi, Melinda Gooderham, C.H. Hong, Mark G. Kirchhof, Charles Lynde, Catherine Maari, Yves Poulin, L. Puig

Bibliographic record

VenueJournal of the European Academy of Dermatology and Venereology · 2021
Typearticle
Languageen
FieldMedicine
TopicDermatology and Skin Diseases
Canadian institutionsCentre de Recherche Dermatologique du Québec MétropolitainHôtel-Dieu de QuébecInnovaderm (Canada)Lynde Centre for DermatologyUniversity of AlbertaSKiN HealthMcMaster UniversityUniversité LavalBC Children's HospitalProbity Medical ResearchSurrey Memorial HospitalUniversity of British ColumbiaOttawa HospitalDermatrials ResearchUniversity of Ottawa
FundersBausch HealthCelgeneAmgenPfizerBC Children's HospitalEli Lilly and Company
KeywordsMedicinePandemicCoronavirus disease 2019 (COVID-19)Position statementDiseaseCoronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Position (finance)Statement (logic)Intensive care medicineVirologyPathologyFamily medicineInfectious disease (medical specialty)EpistemologyOutbreak

Abstract

fetched live from OpenAlex

Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel RNA virus that was declared a global pandemic on 11 March 2020. The efficiency of infection with SARS-CoV-2 is reflected by its rapid global spread. The SARS-CoV-2 pandemic has implications for patients with inflammatory skin diseases on systemic immunotherapy who may be at increased risk of infection or more severe infection. This position paper is a focused examination of current evidence considering the mechanisms of action of immunotherapeutic drugs in relation to immune response to SARS-CoV-2. We aim to provide practical guidance for dermatologists managing patients with inflammatory skin conditions on systemic therapies during the current pandemic and beyond. Considering the limited and rapidly evolving evidence, mechanisms of action of therapies, and current knowledge of SARS-CoV-2 infection, we propose that systemic immunotherapy can be continued, with special considerations for at risk patients or those presenting with symptoms.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.019
metaresearch head score (Gemma)0.046
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.049
Threshold uncertainty score0.098

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0190.046
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.003
Bibliometrics0.0010.001
Science and technology studies0.0050.004
Scholarly communication0.0090.007
Open science0.0030.007
Research integrity0.0490.049
Insufficient payload (model declined to judge)0.0230.015

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.269
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the European Academy of Dermatology and VenereologySame topicDermatology and Skin DiseasesFrench-language works237,207